NCT06885281View on ClinicalTrials.gov

A Study of ZL-1310 in Participants With Selected Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Solid Tumors
Interventions
DRUG

ZL-1310

drug ZL-1310

Trial Locations (9)

10065

RECRUITING

Zai Lab Site 2002, New York

19111

NOT_YET_RECRUITING

Zai Lab Site 2004, Philadelphia

22031

RECRUITING

Zai Lab Site 2006, Fairfax

44106

RECRUITING

Zai Lab Site 2024, Cleveland

94143

NOT_YET_RECRUITING

Zai Lab Site 2001, San Francisco

100142

RECRUITING

Zai Lab Site 1002, Beijing

102200

RECRUITING

Zai Lab Site 1013, Beijing

200000

RECRUITING

Zai Lab Site 1001, Shanghai

510080

RECRUITING

Zai Lab Site 1004, Guangzhou

All Listed Sponsors
collaborator

Zai Lab (US) LLC

INDUSTRY

lead

Zai Lab (Shanghai) Co., Ltd.

INDUSTRY